← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2006Last known activity
Oct 27, 2021
Timeline
1990s
- Jan 1, 1998
Oncolytics Biotech— Founded
Drugs by trial phase (30 distinct, 22 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Colorectal Neoplasms
- Fibrosarcoma
- Glioma
- Histiocytoma
- Histiocytoma, Benign Fibrous
- Histiocytoma, Malignant Fibrous
- Leiomyosarcoma
- Lung Neoplasms
- Melanoma
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Osteosarcoma
- Prostatic Neoplasms
- Sarcoma
- Sarcoma, Ewing
- Sarcoma, Synovial
- Triple Negative Breast Neoplasms
- Urinary Bladder Neoplasms
Recent trials (23)
- NCT07280377Lead sponsorPhase 1/Phase 2Oct 27, 2021
- NCT04445844CollaboratorPhase 2Jul 13, 2020
- NCT04215146Lead sponsorPhase 2Mar 31, 2020
- NCT03605719CollaboratorPhase 1Jul 1, 2019
- NCT04102618Lead sponsorEarly Phase 1Mar 29, 2019
- NCT03015922CollaboratorPhase 1Jun 5, 2017
- NCT02723838Lead sponsorPhase 1Feb 28, 2017
- NCT02620423Lead sponsorPhase 1Dec 1, 2015
- NCT02514382CollaboratorPhase 1Aug 21, 2015
- NCT01708993CollaboratorPhase 2Oct 15, 2012
- NCT01656538CollaboratorPhase 2Jul 30, 2012
- NCT01619813CollaboratorPhase 2Jul 1, 2012
- NCT01622543CollaboratorPhase 2Jun 11, 2012
- NCT01274624Lead sponsorPhase 1Dec 1, 2010
- NCT01166542Lead sponsorPhase 3Jun 1, 2010
Details
- Founded
- Calgary, CA Jan 1, 1998
- Last known activity
- Oct 27, 2021